Neurophet
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Neurophet develops AI-powered software that helps doctors read brain scans, MRI and PET images, to detect and monitor Alzheimer's disease and other neurodegenerative conditions.
Its core products, AQUA and SCALE PET, analyze brain-region volumes and amyloid-protein accumulation to support diagnosis, treatment decisions, and side-effect monitoring. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company supplies its solutions to diagnostic centers, secondary and tertiary hospitals, and global pharmaceutical firms running clinical trials.
Summary is AI-generated and may contain errors · figures from DART filings
Neurophet in five facts
What does Neurophet do?
Neurophet develops AI-powered software that helps doctors read brain scans, MRI and PET images, to detect and monitor Alzheimer's disease and other neurodegenerative conditions.
Where is Neurophet listed and in which sector?
Neurophet (Korean name: 뉴로핏) trades under KRX code 380550 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Information Technology sector, Software.
How large is Neurophet?
Its market capitalisation was US$56.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Neurophet's latest annual revenue and operating profit?
For fiscal year 2025, Neurophet reported revenue of US$2M, an operating loss of US$12.5M and a net loss of US$16.9M, per its annual report on DART (data retrieved from DART on 2026-09-17).
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- DisclosureSep 17
- Supply contract signed
Neurophet disclosed a supply contract, worth US$295K, about 17.21% of its recent annual revenue, running through Jun 2029.
Supply contract · Jun 10 - Material event report (rights offering)
Neurophet disclosed convertible bonds to raise US$10.9M, about 16.3% of its market value.
Capital raise · Apr 10 - Material event report (convertible bonds)
Neurophet disclosed convertible bonds to raise US$10.9M, about 16.3% of its market value.
Capital raise · Apr 10